Eli Lilly announced today that the FDA has approved Cymbalta for the treatment of fibromyalgia!!
Cymbalta joins another medication, Lyrica, as the only medications approved for this disease. This is also the second approval for the use of Cymbalta for pain, the first being diabetic peripheral neuropathic pain.
With fibromyalgia, patients often find that a multi-disciplinary approach works best, and what works for one, may not work for all. This approval is a huge step forward, because another choice in medication improves the chances that even more patients will find relief.
With approximately 5 million people diagnosed with fibromyalgia in the United States, this approval is definitely good news for many!
Posted in Chronic Illness, Chronic Pain, Fibromyalgia, Healthcare, Pain Management at June 16th, 2008. 1 Comment.
